The atypical chemokine receptor CCRL2/ACKR5 as a new player in carcinogenesis and tumor progression
Responsabile Scientifico per UNIBS: Prof. Silvano Sozzani DMMT
Contributo AIRC: € 100.000,00 terza annualità
Bando: Investigator Grant 2017
The atypical chemokine receptor CCRL2/ACKR5 as a new player in carcinogenesis and tumor progression
Responsabile Scientifico per UNIBS: Prof. Silvano Sozzani DMMT
Contributo AIRC: € 100.000,00 terza annualità
Bando: Investigator Grant 2017